• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Severe COVID-19 in Pregnant Versus Nonpregnant Women: Intensive Care Unit Outcomes and Perinatal Risks

tetano

Editor, Senior Moderator
J Med Virol


. 2026 Jul;98(7):e71036.
doi: 10.1002/jmv.71036.
Severe COVID-19 in Pregnant Versus Nonpregnant Women: Intensive Care Unit Outcomes and Perinatal Risks

Jessica Rizzuto[SUP] 1 [/SUP], Justin Z Amarin[SUP] 2 [/SUP], Aleksandra Polic[SUP] 3 [/SUP], Harrison L Howe[SUP] 2 [/SUP], Herdi K Rahman[SUP] 2 [/SUP], Andrew J Spieker[SUP] 4 [/SUP], Todd W Rice[SUP] 5 [/SUP], Natasha B Halasa[SUP] 2 [/SUP], Soha S Patel[SUP] 1 [/SUP], Jennifer L Thompson[SUP] 1 [/SUP]


Affiliations
Abstract

COVID-19 has posed significant challenges worldwide, with pregnant individuals identified as being at increased risk for severe illness and poor outcomes compared to the general population. This study aimed to compare the course of critical illness due to COVID-19 of pregnant patients to nonpregnant reproductive-age women and describe their perinatal outcomes. A retrospective cohort study was conducted including women ages 14-49 years admitted to the intensive care unit (ICU) with COVID-19-related illness from 3/2020 to 2/2022 at Vanderbilt University Medical Center in Nashville, Tennessee. Demographic, clinical characteristics, and outcomes were compared between pregnant/postpartum and nonpregnant patients. Neonatal outcomes were also analyzed. Among 159 women, 35 (22%) were pregnant or postpartum. Pregnant patients had a lower body mass index, were more likely to be publicly insured, and were less likely to have underlying comorbidities. The groups had similar proportions of mechanical ventilation, venous thromboembolism, and death. However, pregnant patients were more likely to require extracorporeal membrane oxygenation (ECMO). The proportion of individuals who were vaccinated against COVID-19 was low in both groups. Of 19 neonates born, the mean gestational age was 32.9 weeks, with 94.7% delivered via cesarean and 78.9% requiring NICU admission. Five intrauterine fetal demises and one neonatal death occurred. Though pregnant patients admitted to the ICU with COVID-19 had fewer comorbidities compared to nonpregnant women, nearly one-fifth of them required ECMO. Pregnant patients with COVID-19 ICU admission face high risks of ECMO, preterm delivery, cesarean, and fetal loss. Improving vaccination uptake is critical, especially in this population.

Keywords: COVID‐19; ECMO; pregnancy.

 
Back
Top